Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

4
Commercial Mortgage REITs: Watch Them Like A Hawk

2018-07-10 seekingalpha
Commercial mortgage REITs have inherently more risk than would warrant a "Sleep Well at Night" designation.
BXMT ARI.PRA LADR ARI ARI.PRC 511505 CAPITALT STWD NHI STWD.WI

27
Beware, The Raised Nail Gets Hammered

2018-07-09 seekingalpha
This now means that we now have 12 commercial mREITs in the REIT Lab, providing investors with plenty of choices.
WBA DTK STWD.WI FNMA FMCKI FMCKJ ABRN CLNC LADR FREGP JCAP.PRB ABR FMCCO FMCCP FMCCM FMCCN FMCCK FMCCL FMCCI FMCCJ FMCCG FMCKO FMCCH FMCKP FMCKM FMCKN FMCKK FMCKL FREJN FREJO BXMT FREJP ABRN.CL FMCC 511505 DG CAPITALT JCAP STWD ABR.PRB ABR.PRC FMCCS ABR.PRA FMCCT

0
Capital Trust Limited - Appointment

2018-07-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
511505 CAPITALT

0
Tynor Orthotics raises Rs 143 crore from Lighthouse, Thuasne

2018-06-18 livemint
Mumbai: Tynor Orthotics Pvt. Ltd, a manufacturer and exporter of orthopedic and fracture aids, has raised Rs 143 crore from private equity fund Lighthouse Funds and Thuasne Participations, a French manufacturer of wearable medical devices, the company said on Monday.
532443 DHANUKA 507717 511505 CAPITALT CERA

14
The Safest Dividend Is The One That's Just Been Raised

2018-06-11 seekingalpha
TRTX has been a great pick and I am so glad that I took the time to include this new REIT in our research.
TMHC BXMT LADR TRTX 511505 CAPITALT PKY

0
Capital Trust Limited - Financial Result Updates

2018-05-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
511505 CAPITALT

0
Capital Trust Limited - Investor Presentation

2018-05-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
511505 CAPITALT

2
SBI, HPCL, IOC, Cipla, Dr Reddy’s, Bosch results

2018-05-21 thehindubusinessline
Close to 60 companies including Andhra Bank, Allcargo, Bata India, Batliboi, Ballarpur, Bemco Hydraulics, Bosch, Bharat Forge, Capital Trust, CARE, Cipla, Dr Reddy’s Laboratories, GE Power, Future Consumer, HPCL, Igarashi Motors, IOC, Jamna Auto, L&T Technology, Minda Industries, SBI, Sonata Soft, Sundaram Clayton, Symphony, TVS Srichakra, Triveni Turbine and VIP Industries will declare their quarterly and full-year results for the period ended March 2018 on Tuesday.
TRITURBINE ENKEIWHEL 500008 BEMHY MINDAIND 532539 532418 533477 ARJQY AMARAJABAT 533655 BATAINDIA TVSSRICHAK 511505 CAPITALT 509243 522650 500493 500043 BHARATFORG ANDHRABANK

35
Amateur Night At Apollo

2018-05-18 seekingalpha
As my readers know, in addition to equity REITs I also cover the growing commercial mortgage REIT sector.
ARI.PRA ARI APO.PRB ARI.PRC APO.PRA APO STWD.WI BXMT LADR TRTX 511505 CAPITALT ACRE STWD

8
Blackstone Mortgage Trust: 7.9% Covered Yield And Capital Upside

2018-05-16 seekingalpha
Blackstone Mortgage Trust has a large, floating-rate senior loan portfolio that is poised to throw off higher NII in a rising rate environment.
BXMT 511505 CAPITALT

445
Replacing A High Yielder

2018-05-10 seekingalpha
I just sold my Gramercy Property Trust shares on the big M&A bump, not willing to put the M&A premium at risk.
STZ.B MTSI STAG.PRB STAG.PRC MS.PRE RCL MS.PRF MS.PRG MS.PRA BAC STOR MSCA AAPL CCL GPT.PRA MS STAG HSY STAG.PRA BAC HSYFB C GILD NRZ GPT.PRB MAIN CCL UTX STZ BRK.A MSCA.CL BXMT MS.PRI MS.PRK 511505 ITW GPT CAPITALT WPC SBUX

16
Price Is What You Pay, Value Is What You Get

2018-05-07 seekingalpha
The reduced overhang and increased liquidity has given Ladder substantially more shelf space and investor appeal.
BXMT LADR 511505 WBA CAPITALT STWD STWD.WI

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...